El efecto de la dieta libre de gluten en la alanina- aminotransferasa (ALT) en pacientes celíacos
DOI:
https://doi.org/10.22516/25007440.5Palavras-chave:
Transaminasas, enfermedad celíaca, alanina-transaminasa, aminotransferasas aspartato, dieta, libre de glutenResumo
Introducción: la enfermedad celíaca es una enfermedad autoinmune provocada por la ingestión de gluten que afecta aproximadamente al 0,5%-1% de la población mundial. Las señales extraintestinales incluyen elevados niveles de alanina-aminotransferasa (ALT). Objetivo: evaluar los efectos de una dieta libre de gluten en los niveles ALT en pacientes con enfermedad celíaca. Métodos: este estudio transversal se llevó a cabo en la clínica ambulatoria de gastroenterología de un hospital universitario. Resultados: se incluyeron veintiséis pacientes con enfermedad celíaca con edad de 34,1 ± 11,4 años; 15,4% fueron hombres. Los sujetos del estudio tenían un nivel promedio de ALT de 54,6 ± 36,3 (mediana 40,5) U/L. Hubo una mayor proporción de individuos con hepatitis B en el grupo con ALT ≥50 U/L en comparación con sujetos con ALT <50 U/L. Entre los pacientes evaluados después del tratamiento con dieta libre de gluten se observó una reducción significativa de los valores de ALT (36,0 versus 31,0 U/l; p= 0,008). Conclusión: el treinta y cinco por ciento de los pacientes con enfermedad celíaca tenía ALT por encima del tercil superior. Se encontraron niveles más altos de ALT en pacientes con hepatitis viral B y en aquéllos que no se adhirieron a la dieta. Hubo una reducción de aminotransferasas como resultado de una dieta libre de gluten.
Downloads
Referências
Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131:1981-2002.
Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, Elitsur Y, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163:286-92.
Guandalini S, Assiri A. Celiac disease: a review. JAMA Pediatr. 2014;168:272-78.
Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE. The prevalence of celiac disease in the United States. Am J Gastroenterol. 2012;107:1538-44; quiz 1537, 1545.
Mustalahti K, Catassi C, Reunanen A, Fabiani E, Heier M, McMillan S, Murray L, et al. The prevalence of celiac disease in Europe: results of a centralized, international mass scree- ning project. Ann Med. 2010;42:587-95.
West J, Logan RF, Hill PG, Lloyd A, Lewis S, Hubbard R, Reader R, et al. Seroprevalence, correlates, and charac- teristics of undetected coeliac disease in England. Gut. 2003;52:960-5.
Antunes H, Abreu I, Nogueiras A, Sá C, Gonçalves C, Cleto P, Garcia F, et al. [First determination of the prevalence of celiac disease in a Portuguese population]. Acta Med Port. 2006;19:115-20.
Alencar ML, Ortiz-Agostinho CL, Nishitokukado L, Damião AO, Abrantes-Lemos CP, Leite AZ, Brito T, et al. Prevalence of celiac disease among blood donors in São Paulo: the most populated city in Brazil. Clinics (Sao Paulo). 2012;67:1013-8.
Fasano A, Catassi C. Clinical practice. Celiac disease. N Engl J Med. 2012;367:2419-26.
Narciso-Schiavon JL, Schiavon LL. Is screening for Celiac Disease Needed in Patients with Liver Disease? International Journal of Celiac Disease 2015;3(3):91-94.
Mounajjed T, Oxentenko A, Shmidt E, Smyrk T. The liver in celiac disease: clinical manifestations, histologic features, and response to gluten free diet in 30 patients. Am J Clin Pathol. 2011;136:128-37.
Volta U, De Franceschi L, Lari F, Molinaro N, Zoli M, Bianchi FB. Coeliac disease hidden by cryptogenic hyper- transaminasaemia. Lancet. 1998;352:26-9.
Kaukinen K, Halme L, Collin P, Farkkila M, Maki M,
Vehmanen P, Partanen J, et al. Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology. 2002;122:881-8.
Singh P, Agnihotri A, Jindal G, Sharma PK, Sharma M, Das P, Gupta D, et al. Celiac disease and chronic liver disease: is there a relationship? Indian J Gastroenterol. 2013;32:404-8.
Sima H, Hekmatdoost A, Ghaziani T, Alavian SM, Mashayekh A, Zali MR. The prevalence of celiac autoanti- bodies in hepatitis patients. Iran J Allergy Asthma Immunol. 2010;9:157-62.
Logan RF, Ferguson A, Finlayson ND, Weir DG. Primary biliary cirrhosis and coeliac disease: an association? Lancet. 1978;1:230-3.
Kingham JG, Parker DR. The association between primary biliary cirrhosis and coeliac disease: a study of relative pre- valences. Gut. 1998;42:120-2.
Volta U. Pathogenesis and clinical significance of liver injury in celiac disease. Clin Rev Allergy Immunol. 2009;36:62-70.
Rubio-Tapia A, Murray JA. The liver in celiac disease.
Hepatology. 2007;46:1650-58.
Green PH, Jabri B. Celiac disease. Annu Rev Med.
;57:207-21.
Pereira MA, Ortiz-Agostinho CL, Nishitokukado I, Sato
MN, Damião AO, Alencar ML, Abrantes-Lemos CP, et al. Prevalence of celiac disease in an urban area of Brazil with predominantly European ancestry. World J Gastroenterol. 2006;12:6546-50.
Gandolfi L, Pratesi R, Cordoba JC, Tauil PL, Gasparin M, Catassi C. Prevalence of celiac disease among blood donors in Brazil. Am J Gastroenterol. 2000;95:689-92.
Novacek G, Miehsler W, Wrba F, Ferenci P, Penner E, Vogelsang H. Prevalence and clinical importance of hyper- transaminasaemia in coeliac disease. Eur J Gastroenterol Hepatol. 1999;11:283-88.
Zanini B, Baschè R, Ferraresi A, Pigozzi MG, Ricci C, Lanzarotto F, et al. Factors that contribute to hypertran- saminasemia in patients with celiac disease or functional gastrointestinal syndromes. Clin Gastroenterol Hepatol. 2014;12(5):804-10.e2.
Bardella MT, Fraquelli M, Quatrini M, Molteni N, Bianchi P, Conte D. Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet. Hepatology.
;22:833-6.
Casella G, Antonelli E, Di Bella C, Villanacci V, Fanini L,
Baldini V, Bassotti G. Prevalence and causes of abnormal liver function in patients with coeliac disease. Liver Int. 2013;33:1128-31.
Kochhar R, Sachdev S, Aggarwal A, Sharma V, Prasad KK, Singh G, Nain CK, et al. Prevalence of coeliac disease in healthy blood donors: a study from north India. Dig Liver Dis 2012;44:530-32.
Remes-Troche JM, Ramírez-Iglesias MT, Rubio-Tapia A, Alonso-Ramos A, Velazquez A, Uscanga LF. Celiac disease could be a frequent disease in Mexico: prevalence of tissue transglutaminase antibody in healthy blood donors. J Clin Gastroenterol. 2006;40:697-700.
Alavi Moghaddam M, Rostami Nejad M, Shalmani HM, Rostami K, Nazemalhosseini Mojarad E, Aldulaimi D, et al. The effects of gluten-free diet on hypertransaminasemia in patients with celiac disease. Int J Prev Med. 2013;4:700-4.
Korpimäki S, Kaukinen K, Collin P, Haapala AM, Holm P, Laurila K, Kurppa K, et al. Gluten-sensitive hypertransami- nasemia in celiac disease: an infrequent and often subclinical finding. Am J Gastroenterol. 2011;106:1689-96.
Cordoba J, O’Riordan K, Dupuis J, Borensztajin J, Blei AT: Diurnal variation of serum alanine transaminase activity in chronic liver disease. In: Hepatology. Volume 28. United states, 1998;1724-25.
Fraser CG. Biological variation in clinical chemistry. An update: collated data, 1988-1991. Arch Pathol Lab Med. 1992;116:916-23.
Salvaggio A, Periti M, Miano L, Tavanelli M, Marzorati D. Body mass index and liver enzyme activity in serum. Clin Chem. 1991;37:720-723.
Ono T, Kitaguchi K, Takehara M, Shiiba M, Hayami K. Serum-constituents analyses: effect of duration and tempe- rature of storage of clotted blood. Clin Chem. 1981;27:35-8.
Volta U, Granito A, De Franceschi L, Petrolini N, Bianchi FB. Anti tissue transglutaminase antibodies as predictors of silent coeliac disease in patients with hypertransaminasae- mia of unknown origin. Dig Liver Dis. 2001;33:420-5.
Korponay-Szabo IR, Halttunen T, Szalai Z, Laurila K, Kiraly R, Kovacs JB, Fesus L, et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoanti- bodies. Gut. 2004;53:641-8.
Caglar E, Ugurlu S, Ozenoglu A, Can G, Kadioglu P, Dobrucali A. Autoantibody frequency in celiac disease. Clinics (Sao Paulo). 2009;64:1195-1200.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as ceden sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.
Métricas do artigo | |
---|---|
Vistas abstratas | |
Visualizações da cozinha | |
Visualizações de PDF | |
Visualizações em HTML | |
Outras visualizações |